The use of digital twins for virtual process optimization is a key component of the digital transformation strategy in the pharmaceutical industry, but their development and deployment require the combined use of a wide range of technologies such as physics-based simulation, machine learning, high-performance computing, real-time dashboarding and IoT. Altair is uniquely positioned to deliver an end-to-end solution in this context.